Berlin Heals has developed an innovative and disruptive method to treat heart failure, the number one cause of death worldwide. In comparison to other devices, our pilot study indicates that our implantable microcurrent device results in an extremely low level of side effects with comparable clinical effects.
Berlin Heals Holding AG is a Swiss joint stock company founded in 2014 by a serial medical entrepreneur in the field of heart failure treatment.
Berlin Heals has developed a novel implantable electroceutical device with the aim to treat heart failure using electrical microcurrent to induce a progression from reverse modeling to true myocardial recovery.
Heart failure is a generic tearm that describes the condition of a heart that is no longer able to pump a sufficient amount of blood to supply all organs with the necessary level of oxygen.
Heart failure is progressive, making it more difficult to treat over time. It leads to death or highly invasive, burdensome, and costly procedures in its end-stage.
The potential global market demand for our device is tremendous, as it offers a treatment option for patients with heart failure who cannot yet be adequately treated because they either do not meet the criteria for an implantation or because the ensuing side effects are detrimental.
Berlin Heals has developed a novel implantable electroceutical device with the aim to heal heart failure.
Our cardio microcurrent device (C-MIC) has the potential to establish a new, affordable standard of treatment for heart failure.
WE HAVE INITIATED A DUAL CENTER PILOT STUDY WITH LAST PATIENT OUT IN APRIL 2020.
C-MIC is by far the most promising treatment for heart failure. There is no comparable application known to us.
Heart failure occurs when the heart muscle is unable to pump enough blood through the heart to meet the body's needs for blood and oxygen. Heart failure usually results in an enlarged heart. At first the heart tries to make up for this by:
Heart failure occurs when the heart muscle is unable to pump enough blood through the heart to meet the body's needs for blood and oxygen. Heart failure usually results in an enlarged heart. At first the heart tries to make up for this by:
Experiments with cardiomycytes exposed to microcurrent in 24 well culture plates.
Promising results of implanted epicardial left ventricular patch electrodes.
Incorporation of Subsidiary GmbH in Berlin and Mother Company in Zug.
Fully ISO certified according to ISO 13485:2016.
First serial production of the C-MIC device.
Successfully completed pilot trial in 10 patients between April 2019-April 2020
Extensive basic research indicates that electrical current of different ... More
First-In-Human Study is showing significant improvements from the start (7 ... More
The New York Heart Association classifies the severity of heart failure ... More
Berlin Heals has started its Pilot Study with its novel C-MIC device at two ... More
Berlin Heals presents at the Annual Meeting of the International Society of ... More
Our Co-founder, Dr J. Mueller, is a highly decorated MD and recognized ... More
Berlin Heals invited to present C-MIC technology and pre-clinical results ... More
Dr J. Mueller conducted experiments early on to prove that microcurrent can ... More
Read the Latest Paper on Effects of Microcurrent, published in ESC Heart ... More
Berlin Heals Holding AG is a life science company located in Zug, Switzerland with an R&D-branch company - Berlin Heals GmbH - in Berlin, Germany.
Co-founder and Chairman of Berlin Heals Holding AG and Co-CEO of Berlin Heals GmbH
Dr Mueller is a physician and also holds a Master of Engineering from the Technical University of Berlin. He was a physician at the Department of ... Cardiac Surgery at the German Heart Institute Berlin for almost 20 years, the last eight of which as Senior Physician of the Cardiac Surgery Department. Amongst other companies, he founded Berlin Heart in 1997, in which he was member of the BOD and CEO. Upon leaving the Company in 2010, he presided over more than 240 employees. Dr Mueller has published multiple scientific papers and has received many national and international awards for innovation. More
Co-founder, CEO, and Board Member of Berlin Heals Holding AG
Marko Bagaric is responsible for the Company’s general business development and investor relations. At the age of 22 he founded his own business ... and started to gather insights in the real estate and financial sectors. He brings substantial knowhow in private equity and corporate investment. Since the establishment of his own company, Minerva Partners AG in 2011, he has repeatedly demonstrated his ability to support entrepreneurs with financing and management needs. Over the last ten years his focus has been on the health sector where he has co-launched and successfully advised a number of startups. More
Co-founder and Co-CEO of Berlin Heals GmbH
Dr Peter Goettel is a physician and holds an engineering degree in Medical Computer Sciences from the University of Applied Sciences, Berlin. He was ... trained in heart surgery at the Charité Medical Center and at the German Heart Institute. Later he spent 10 years with Berlin Heart GmbH where he was involved in the development, clinical evaluation, and market introduction of the world’s first magnetically levitated rotary blood pump for the treatment of heart failure patients. He also introduced the Company’s pediatric mechanical circulatory support system into the US market and was head of the global sales department. More
Investor, Board Member of Berlin Heals Holding AG
Reto Moro has extensive experience in the banking sector, first with Citicorp Investment Bank followed by Merrill Lynch Capital Markets and Salomon ... Brothers Finanz AG. He founded RTM Financial Coaching AG in 1996, a company successfully active in the areas of asset management, investment counseling, and financing. Mr. Moro is a profound specialist in capital market issues for solutions sought by sophisticated private clients with regards to their portfolio management needs. Due to his vast network, Reto Moro has successfully contributed to the financing needs of various venture capital firms. More
Member of the Scientific Advisory Board, Medical Director German Heart Institute, Berlin, Germany
Member of the Scientific Advisory Board, Head of Cardiology, Angiology and Rhythmology, Kantonsspital Wetzikon, Switzerland
Member of the Scientific Advisory Board, Medical Director and Chief of Internal Medicine, Kantonsspital, Wetzikon, Professor of Cardiology, University of Zurich, Switzerland
Member of the Scientific Advisory Board, Head of Cell Culture Unit, Dept. of Biomedical Research, Medical University Vienna, Austria
Want to know more about us? We will be pleased to provide you with further information. Please fill in the following form.